TORONTO, ON - TheNewswire - May 13, 2025 - StageZero Life Sciences, Ltd. (TSX:SZLS) (OTCQB:SZLSF) (" StageZero " or the " Company "), and ElevationMD ( “ElevationMD”) today announced the introduction of Aristotle and AVRT for the early detection of cancer as well as screening for metabolic markers for identifying and managing the early warning signs of chronic disease for the prevention of cancer. StageZero is an integrated... Read More